The nutraceutical benefit, part II: Ginseng

Nutrition

Volumn 16, Issue 5, 2000, Pages 391-392

  Sato, Tomoi ^a   Miyata, Go ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GINSENG EXTRACT; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ASIA; CANCER PREVENTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNITY; IMMUNOSTIMULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUTRIENT; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALIA; PANAX GINSENG;

EID: 0034192072     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00222-7     Document Type: Note

References (7)

1. Cui J., Garle M., Eneroth P., Björkhem I. What do commercial ginseng preparations contain? Lancet. 344:1994;134.
2. Jie Y.H., Cammisuli S., Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions. 15:1984;386.
3. 1 from Panax ginseng. Jpn J Pharmacol. 54:1990;447.
4. Yang G. Immunologic effect of traditional Chinese drugs. Chin Med J. 109:1996;59.
5. Yun T.K., Choi S.Y. Non-organ specific cancer prevention of ginseng a prospective study in Korea . Int J Epidemiol. 27:1998;359.
6. Yun Y.S., Jo S.K., Moon H.S., et al. Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethan and benzo(a)pyrene. Cancer Detect Prev. 1:1987;301.
7. Sohn J, Lee CH, Chung DJ, et al. Effect of petroleum ether extract of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells. Exp Mol Med 1998;30:47.